Idiosyncratic liver injury induced by vildagliptin with successful switch to linagliptin in a hemodialyzed diabetic patient

Diabetes Care. 2014 Sep;37(9):e198-9. doi: 10.2337/dc14-1252.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adamantane / adverse effects
  • Adamantane / analogs & derivatives*
  • Aged
  • Chemical and Drug Induced Liver Injury / diagnosis*
  • Chemical and Drug Induced Liver Injury / drug therapy*
  • Chemical and Drug Induced Liver Injury / etiology
  • Diabetes Mellitus / physiopathology*
  • Diabetic Nephropathies / complications*
  • Diabetic Nephropathies / therapy
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Linagliptin
  • Nitriles / adverse effects*
  • Purines / therapeutic use*
  • Pyrrolidines / adverse effects*
  • Quinazolines / therapeutic use*
  • Renal Dialysis*
  • Vildagliptin

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Nitriles
  • Purines
  • Pyrrolidines
  • Quinazolines
  • Linagliptin
  • Vildagliptin
  • Adamantane